首页 › 基金 › Acasta Partners UK LLP › ARWR

Acasta Partners UK LLP 对 ARWR 的持仓历史

ARROWHEAD PHARMACEUTICALS IN · 医疗保健

Acasta Partners UK LLP 在 Q3 2026 的 13F 申报中披露持有 ARWR(ARROWHEAD PHARMACEUTICALS IN)1,500,000 股,市值约 US$1.5M,约占其申报组合的 0.81%,在其申报持仓中市值排名第 11 位。 Acasta Partners UK LLP 最近 3 个申报季度中有 3 个季度披露了 ARWR 持仓,最早可追溯至 Q1 2026。

最新持仓 (Q3 2026)1.50M 股
申报持仓市值$1.54M
组合权重0.81%
首次申报Q1 2026
最近变动持有
更新于2026-10-09

最后更新: 2026-10-09 · 来源: SEC EDGAR Form 13F-HR

Acasta Partners UK LLP 对 ARWR 的持仓演变

Acasta Partners UK LLP 于 Q1 2026 首次披露 ARWR 持仓:400,000 股(约 US$415K)。 该持仓在 Q2 2026 达到峰值 1,500,000 股,市值约 US$1.8M。 在 3 次申报中,Acasta Partners UK LLP 1 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 1,500,000 股、市值约 US$1.5M。 持仓曾出现大幅变动:Q2 2026 增持约 275% (随后一个季度股价下跌 20%)。

逐季持仓明细

季度股数金额变化
Q1 2026 400.00K $414.63K 新进
Q2 2026 1.50M $1.81M 增持
Q3 2026 1.50M $1.54M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ARWR 与 13F 数据

ARWR(ARROWHEAD PHARMACEUTICALS IN)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 ARWR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$925.6M), FRED ALGER MANAGEMENT, LLC (US$269.1M), BAKER BROS. ADVISORS LP (US$162.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ARWR 的基金

查看 ARWR 的全部基金持有人 →

常见问题

How long has Acasta Partners UK LLP held ARWR?

Acasta Partners UK LLP has disclosed ARWR holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Acasta Partners UK LLP's current position in ARWR?

As of Q3 2026, Acasta Partners UK LLP holds 1.50M shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), valued at $1.54M, representing 0.81% of its reported portfolio and ranking #11.

Has Acasta Partners UK LLP been buying or selling ARWR?

In the latest 13F filing (Q3 2026), Acasta Partners UK LLP held unchanged its position in ARWR. The position peaked in Q2 2026 at 1.50M shares.

Which other funds hold ARWR?

Other major institutional holders of ARWR include Avoro Capital Advisors LLC, FRED ALGER MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.